![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1-dichloroethene | increases expression | ISO | RGD:1551522 | 6480464 | vinylidene chloride results in increased expression of RGS19 mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | increases expression | ISO | RGD:1551522 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of RGS19 mRNA | CTD | PMID:22206623 | 1,3,5-trinitro-1,3,5-triazinane | increases expression | EXP | | 6480464 | cyclonite results in increased expression of RGS19 mRNA | CTD | PMID:25559034 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1551522 | 6480464 | Ethinyl Estradiol results in increased expression of RGS19 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of RGS19 mRNA | CTD | PMID:17351261 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1551522 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RGS19 mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | ISO | RGD:1353904 | 6480464 | [Estradiol binds to ESR2 protein] which results in increased expression of RGS19 mRNA | CTD | PMID:20404318 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1551522 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RGS19 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RGS19 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RGS19 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1551522 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RGS19 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RGS19 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1551522 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RGS19 mRNA | CTD | PMID:17942748, PMID:19770486 | 2-methylcholine | affects expression | ISO | RGD:1353904 | 6480464 | beta-methylcholine affects the expression of RGS19 mRNA | CTD | PMID:21179406 | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1551522 | 6480464 | 4, 4'-diaminodiphenylmethane results in increased expression of RGS19 mRNA | CTD | PMID:18648102 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1551522 | 6480464 | Fenretinide results in decreased expression of RGS19 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of RGS19 mRNA | CTD | PMID:24780913 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of RGS19 mRNA | CTD | PMID:31881176 | acrylamide | decreases expression | ISO | RGD:1353904 | 6480464 | Acrylamide results in decreased expression of RGS19 mRNA | CTD | PMID:32763439 | aflatoxin B1 | increases methylation | ISO | RGD:1353904 | 6480464 | Aflatoxin B1 results in increased methylation of RGS19 intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | decreases methylation | ISO | RGD:1353904 | 6480464 | aflatoxin B2 results in decreased methylation of RGS19 promoter | CTD | PMID:30157460 | Allylamine | affects expression | EXP | | 6480464 | Allylamine affects the expression of RGS19 mRNA | CTD | PMID:15910882 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of RGS19 mRNA | CTD | PMID:16483693 | antirheumatic drug | decreases expression | ISO | RGD:1353904 | 6480464 | Antirheumatic Agents results in decreased expression of RGS19 mRNA | CTD | PMID:24449571 | benzo[a]pyrene | decreases expression | ISO | RGD:1551522 | 6480464 | Benzo(a)pyrene results in decreased expression of RGS19 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases expression | ISO | RGD:1353904 | 6480464 | Benzo(a)pyrene results in increased expression of RGS19 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | increases methylation | ISO | RGD:1353904 | 6480464 | Benzo(a)pyrene results in increased methylation of RGS19 promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RGS19 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | RGD:1353904 | 6480464 | bisphenol A analog results in decreased expression of RGS19 mRNA | CTD | PMID:32387340 | bisphenol A | affects methylation | ISO | RGD:1551522 | 6480464 | bisphenol A affects the methylation of RGS19 promoter | CTD | PMID:27334623 | bisphenol A | decreases methylation | ISO | RGD:1551522 | 6480464 | bisphenol A results in decreased methylation of RGS19 promoter | CTD | PMID:27312807 | caffeine | increases phosphorylation | ISO | RGD:1353904 | 6480464 | Caffeine results in increased phosphorylation of RGS19 protein | CTD | PMID:35688186 | carbon nanotube | increases expression | ISO | RGD:1551522 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chloroprene | decreases expression | ISO | RGD:1551522 | 6480464 | Chloroprene results in decreased expression of RGS19 mRNA | CTD | PMID:23125180 | choline | affects expression | ISO | RGD:1353904 | 6480464 | Choline affects the expression of RGS19 mRNA | CTD | PMID:17616785 | choline | multiple interactions | ISO | RGD:1551522 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS19 mRNA | CTD | PMID:20938992 | cisplatin | increases expression | ISO | RGD:1353904 | 6480464 | Cisplatin results in increased expression of RGS19 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | RGD:1353904 | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of RGS19 mRNA | CTD | PMID:27392435 | clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of RGS19 mRNA | CTD | PMID:17602206 | copper atom | multiple interactions | ISO | RGD:1353904 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RGS19 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RGD:1353904 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RGS19 mRNA | CTD | PMID:20971185 | cyclosporin A | decreases expression | ISO | RGD:1353904 | 6480464 | Cyclosporine results in decreased expression of RGS19 mRNA | CTD | PMID:20106945 | dextran sulfate | multiple interactions | ISO | RGD:1551522 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RGS19 mRNA | CTD | PMID:29950665 | diazinon | increases methylation | ISO | RGD:1353904 | 6480464 | Diazinon results in increased methylation of RGS19 gene | CTD | PMID:22964155 | dibutyl phthalate | decreases expression | ISO | RGD:1551522 | 6480464 | Dibutyl Phthalate results in decreased expression of RGS19 mRNA | CTD | PMID:17361019, PMID:21266533 | doxorubicin | decreases expression | ISO | RGD:1353904 | 6480464 | Doxorubicin results in decreased expression of RGS19 mRNA | CTD | PMID:29803840 | ethanol | affects expression | ISO | RGD:1551522 | 6480464 | Ethanol affects the expression of RGS19 mRNA | CTD | PMID:30319688 | flavonoids | decreases expression | EXP | | 6480464 | Flavonoids results in decreased expression of RGS19 mRNA | CTD | PMID:18035473 | flusilazole | affects expression | ISO | RGD:1551522 | 6480464 | flusilazole affects the expression of RGS19 mRNA | CTD | PMID:21195148 | folic acid | multiple interactions | ISO | RGD:1551522 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS19 mRNA | CTD | PMID:20938992 | folic acid | decreases expression | ISO | RGD:1551522 | 6480464 | Folic Acid results in decreased expression of RGS19 mRNA | CTD | PMID:25629700 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of RGS19 mRNA | CTD | PMID:33387578 | hexaconazole | affects expression | ISO | RGD:1551522 | 6480464 | hexaconazole affects the expression of RGS19 mRNA | CTD | PMID:21195148 | ketamine | decreases expression | EXP | | 6480464 | Ketamine results in decreased expression of RGS19 mRNA | CTD | PMID:20080153 | L-methionine | multiple interactions | ISO | RGD:1551522 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS19 mRNA | CTD | PMID:20938992 | lead diacetate | decreases expression | ISO | RGD:1551522 | 6480464 | lead acetate results in decreased expression of RGS19 mRNA | CTD | PMID:21829687 | lipopolysaccharide | multiple interactions | ISO | RGD:1353904 | 6480464 | [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RGS19 mRNA | CTD | PMID:35811015 | nickel atom | increases expression | ISO | RGD:1353904 | 6480464 | Nickel results in increased expression of RGS19 mRNA | CTD | PMID:25583101 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RGS19 mRNA | CTD | PMID:33387578 | pirinixic acid | decreases expression | ISO | RGD:1551522 | 6480464 | pirinixic acid results in decreased expression of RGS19 mRNA | CTD | PMID:18445702 | quercetin | increases expression | ISO | RGD:1353904 | 6480464 | Quercetin results in increased expression of RGS19 mRNA | CTD | PMID:21632981 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | RGD:1353904 | 6480464 | [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RGS19 mRNA | CTD | PMID:35811015 | sodium arsenite | decreases expression | ISO | RGD:1353904 | 6480464 | sodium arsenite results in decreased expression of RGS19 mRNA | CTD | PMID:34032870 | sodium dichromate | decreases expression | ISO | RGD:1353904 | 6480464 | sodium bichromate results in decreased expression of RGS19 mRNA | CTD | PMID:17685462 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of RGS19 mRNA | CTD | PMID:19281266 | sunitinib | increases expression | ISO | RGD:1353904 | 6480464 | Sunitinib results in increased expression of RGS19 mRNA | CTD | PMID:31533062 | tetrachloromethane | increases expression | ISO | RGD:1551522 | 6480464 | Carbon Tetrachloride results in increased expression of RGS19 mRNA | CTD | PMID:27339419, PMID:31919559 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of RGS19 mRNA | CTD | PMID:23411599, PMID:34492290 | titanium dioxide | multiple interactions | ISO | RGD:1551522 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RGS19 mRNA | CTD | PMID:29950665 | triadimefon | affects expression | ISO | RGD:1551522 | 6480464 | triadimefon affects the expression of RGS19 mRNA | CTD | PMID:21195148 | trichostatin A | affects expression | ISO | RGD:1353904 | 6480464 | trichostatin A affects the expression of RGS19 mRNA | CTD | PMID:28542535 | urethane | decreases expression | ISO | RGD:1353904 | 6480464 | Urethane results in decreased expression of RGS19 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | RGD:1551522 | 6480464 | Valproic Acid results in decreased expression of RGS19 mRNA | CTD | PMID:20546886, PMID:21427059 | valproic acid | increases methylation | ISO | RGD:1353904 | 6480464 | Valproic Acid results in increased methylation of RGS19 gene | CTD | PMID:29154799 | zinc atom | decreases expression | EXP | | 6480464 | Zinc results in decreased expression of RGS19 mRNA | CTD | PMID:17074742 | zinc sulfate | decreases expression | EXP | | 6480464 | Zinc Sulfate results in decreased expression of RGS19 mRNA | CTD | PMID:17074742 | zinc(0) | decreases expression | EXP | | 6480464 | Zinc results in decreased expression of RGS19 mRNA | CTD | PMID:17074742 | |